Seegene, Inc. manufactures In Vitro Diagnostic (IVD) products mainly through molecular diagnostic method.  The Company provides diagnostic & screening products for cancer, sepsis, influenza and virus infection.

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Decision on Cash Dividend and Dividend in Kind(ë¶ê¸°ë°°ë¹)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Seegene Inc (096530 KS)

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Decision on Cash Dividend and Dividend in Kind(ë¶ê¸°ë°°ë¹)

Prior Notice on Disclosure of Final Earnings

Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading)

(Forewarning) Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Decision on Cash Dividend and Dividend in Kind(ë¶ê¸°ë°°ë¹)

Prior Notice on Disclosure of Final Earnings

Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading)

(Forewarning) Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading)

Decision on Cash Dividend and Dividend in Kind(ë¶ê¸°ë°°ë¹)